SEARCH

SEARCH BY CITATION

References

  • Aoun, P., Blair, H.E., Smith, L.M., Dave, B.J., Lynch, J., Weisenburger, D.D., Pavletic, S.Z. & Sanger, W.G. (2004) Fluorescence in situ hybridisation detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma. Leukemia and Lymphoma, 45, 15951603.
  • Bacher, U., Kern, W., Schoch, C., Hiddemann, W. & Haferlach, T. (2004) Discrimination of chronic lymphocytic leukemia (CLL) and CLL/PL by cytomorphology can clearly be correlated to specific genetic markers as investigated by interphase fluorescence in situ hybridization (FISH). Annals of Hematology, 83, 349355.
  • Chevallier, P., Penther, D., Avet-Loiseau, H., Robillard, N., Ifrah, N., Mahe, B., Hamidou, M., Maisonneuve, H., Moreau, P., Jardel, H., Harousseau, J.L., Bataille, R. & Garand, R. (2002) CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia. British Journal of Haematology, 116, 142150.
  • Criel, A., Verhoef, G., Vlietinck, R., Mecucci, C., Billiet, J., Michaux, L., Meeus, P., Louwagie, A., Van Orshoven, A., Van Hoof, A., Boogaerts, M., Van den Berghe, H. & De Wolf-Peeters, C. (1997) Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases. British Journal of Haematology, 97, 383391.
  • Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. & Chiorazzi, N. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, 18401847.
  • Del Poeta, G., Maurillo, L., Venditti, A., Buccisano, F., Epiceno, A.M., Capelli, G., Tamburini, A., Suppo, G., Battaglia, A., Del Principe, M.I., Del Moro, B., Masi, M. & Amadori, S. (2001) Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood, 98, 26332639.
  • Dewald, G.W., Brockman, S.R., Paternoster, S.F., Bone, N.D., O'Fallon, J.R., Allmer, C., James, C.D., Jelinek, D.F., Tschumper, R.C., Hanson, C.A., Pruthi, R.K., Witzig, T.E., Call, T.G. & Kay, N.E. (2003) Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia. British Journal of Haematology, 121, 287295.
  • Dickinson, J.D., Smith, L.M., Sanger, W.G., Zhou, G., Townley, P., Lynch, J.C., Pavletic, Z.S., Bierman, P.J. & Joshi, S.S. (2005) Unique gene expression and clinical characteristics are associated with the 11q23 deletion in chronic lymphocytic leukaemia. British Journal of Haematology, 128, 460471.
  • DiGiuseppe, J.A. & Borowitz, M.J. (1998) Clinical utility of flow cytometry in the chronic lymphoid leukemias. Seminars in Oncology, 25, 610.
  • Dohner, H., Fischer, K., Bentz, M., Hansen, K., Benner, A., Cabot, G., Diehl, D., Schlenk, R., Coy, J. & Stilgenbauer, S. (1995) p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood, 85, 15801589.
  • Dohner, H., Stilgenbauer, S., James, M.R., Benner, A., Weilguni, T., Bentz, M., Fischer, K., Hunstein, W. & Lichter, P. (1997) 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood, 89, 25162522.
  • Dohner, H., Stilgenbauer, S., Dohner, K., Bentz, M. & Lichter, P. (1999) Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. Journal of Molecular Medicine, 77, 266281.
  • Dohner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Krober, A., Bullinger, L., Dohner, K., Bentz, M. & Lichter, P. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. New England Journal of Medicine, 343, 19101916.
  • Doneda, L., Montillo, M., Intropido, L., Tedeschi, A., Morra, E. & Larizza, L. (2003) Interphase fluorescence in situ hybridization analysis of del(11)(q23) and del(17)(p13) in chronic lymphocytic leukemia. A study of 40 early-onset patients. Cancer Genetics and Cytogenetics, 140, 3136.
  • Finn, W.G., Thangavelu, M., Yelavarthi, K.K., Goolsby, C.L., Tallman, M.S., Traynor, A. & Peterson, L.C. (1996) Karyotype correlates with peripheral blood morphology and immunophenotype in chronic lymphocytic leukemia. American Journal of Clinical Pathology, 105, 458467.
  • Ghia, P., Guida, G., Stella, S., Gottardi, D., Geuna, M., Strola, G., Scielzo, C. & Caligaris-Cappio, F. (2003) The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression. Blood, 101, 12621269.
  • Glassman, A.B. (1998) Cytogenetics, in situ hybridization and molecular approaches in the diagnosis of cancer. Annals of Clinical and Laboratory Science, 28, 324330 (Review).
  • Glassman, A.B. & Hayes, K.J. (2005) The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics, 158, 8891.
  • Goorha, S., Glenn, M.J., Drozd-Borysiuk, E. & Chen, Z. (2004) A set of commercially available fluorescent in-situ hybridization probes efficiently detects cytogenetic abnormalities in patients with chronic lymphocytic leukemia. Genetics in Medicine, 6, 4853.
  • Gozzetti, A., Crupi, R., Tozzuoli, D., Raspadori, D., Forconi, F. & Lauria, F. (2004) Molecular cytogenetic analysis of B-CLL patients with aggressive disease. Hematology, 9(5–6), 383385.
  • Hernandez, J.M., Mecucci, C., Criel, A., Meeus, P., Michaux, I., Van Hoof, A., Verhoef, G., Louwagie, A., Scheiff, J.M., Michaux, J.L., Boogaerts, M. & Van Den Berghe, H. (1995) Cytogenetic analysis of B cell chronic lymphoid leukemias classified according to morphologic and immunophenotypic (FAB) criteria. Leukemia, 9, 21402146.
  • Ibrahim, S., Keating, M., Do, K.A., O'Brien, S., Huh, Y.O., Jilani, I., Lerner, S., Kantarjian, H.M. & Albitar, M. (2001) CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood, 98, 181186.
  • Jahrsdorfer, B., Wooldridge, J.E., Blackwell, S.E., Taylor, C.M., Link, B.K. & Weiner, G.J. (2005) Good prognosis cytogenetics in B-cell chronic lymphocytic leukemia is associated in vitro with low susceptibility to apoptosis and enhanced immunogenicity. Leukemia, 19, 759766.
  • Jelinek, D.F., Tschumper, R.C., Geyer, S.M., Bone, N.D., Dewald, G.W., Hanson, C.A., Stenson, M.J., Witzig, T.E., Tefferi, A. & Kay, N.E. (2001) Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia. British Journal of Haematology, 115, 854861.
  • Juliusson, G. & Gahrton, G. (1990) Chromosome aberrations in B-cell chronic lymphocytic leukemia. Pathogenetic and clinical implications. Cancer Genetics and Cytogenetics, 45, 143160.
  • Juliusson, G., Oscier, D.G., Fitchett, M., Ross, F.M., Stockdill, G., Mackie, M.J., Parker, A.C., Castoldi, G.L., Guneo, A., Knuutila, S., Elonen, E. & Gahrton, G. (1990) Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. New England Journal of Medicine, 323, 720724.
  • Krober, A., Seiler, T., Benner, A., Bullinger, L., Bruckle, E., Lichter, P., Dohner, H. & Stilgenbauer, S. (2002) V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood, 100, 14101416.
  • Kurec, A.S., Threatte, G.A., Gottlieb, A.J., Smith, J.R., Anderson, J. & Davey, F.R. (1992) Immunophenotypic subclassification of chronic lymphocytic-leukemia (CLL). British Journal of Haematology, 81, 4551.
  • Lens, D., Dyer, M.J., Garcia-Marco, J.M., De Schouwer, P.J., Hamoudi, R.A., Jones, D., Farahat, N., Matutes, E. & Catovsky, D. (1997) p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis. British Journal of Haematology, 99, 848857.
  • Matutes, E., Oscier, D., Garcia-Marco, J., Ellis, J., Copplestone, A., Gillingham, R., Hamblin, T., Lens, D., Swansbury, G.J. & Catovsky, D. (1996) Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. British Journal of Haematology, 92, 382388.
  • Muller-Hermelink, H.K., Catovsky, D., Montserrat, E. & Heimpel, H. (2001) Chronic lymphocytic leukemia/small lymphocytic leukemia. In: Pathology and Genetics of Tumours of Haematomoietic and Lymphoid Tissues (ed. by E.S.Jaffe, N.L.Harris, H.Stein and J.W.Vardiman ), pp. 127130. IARC Press, Lyon.
  • Neilson, J.R., Auer, R., White, D., Bienz, N., Waters, J.J., Whittaker, J.A., Milligan, D.W. & Fegan, C.D. (1997) Deletions at 11q identify a subset of patients with typical CLL who show consistent disease progression and reduced survival. Leukemia, 11, 19291932.
  • Nowakowski, G.S., Dewald, G.W., Hoyer, J.D., Paternoster, S.F., Stockero, K.J., Fink, S.R., Smoley, S.A., Remstein, E.D., Phyliky, R.L., Call, T.G., Shanafelt, T.D., Kay, N.E. & Zent, C.S. (2005) Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia. British Journal of Haematology, 130, 3642.
  • Sindelarova, L., Michalova, K., Zemanova, Z., Ransdorfova, S., Brezinova, J., Pekova, S., Schwarz, J., Karban, J. & Cmunt, E. (2005) Incidence of chromosomal anomalies detected with FISH and their clinical correlations in B-chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics, 160, 2734.
  • Stilgenbauer, S. & Dohner, H. (2004) Molecular genetics and its clinical relevance. Hematology/Oncology Clinics of North America, 18, 827848, viii.
  • Stilgenbauer, S., Bullinger, L., Benner, A., Wildenberger, K., Bentz, M., Dohner, K., Ho, A.D., Lichter, P. & Dohner, H. (1999) Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia. Leukemia, 13, 13311334.
  • Tefferi, A., Bartholmai, B.J., Witzig, T.E., Jenkins, R.B., Li, C.Y., Hanson, C.A., Mesa, R.A. & Phyliky, R.L. (1997) Clinical correlations of immunophenotypic variations and the presence of trisomy 12 in B-cell chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics, 95, 173177 (Review).
  • Zhang, Y., Weber-Matthiesen, K., Siebert, R., Matthiesen, P. & Schlegelberger, B. (1997) Frequent deletions of 6q23–24 in B-cell non-Hodgkin's lymphomas detected by fluorescence in situ hybridization. Genes, Chromosomes and Cancer, 18, 310313.